A simple, flexible, nonfluorescent system for the automated screening of neurite outgrowth.
Measurement of neurite outgrowth is a common assay of neurotrophic activity. However, currently available techniques for measuring neurite outgrowth are either time or resource intensive. The authors established a system in which chronic treatment of a subcloned SH-SY5Y cell line with aphidicolin and various concentrations of nerve growth factor (NGF) induced discernable alterations in proliferation and differentiation. Cells were fixed, labeled with a nonfluorescent dye, and evaluated both manually and with an automated analysis system. NGF increased multiple parameters of differentiation, including neurite length, the proportion of cells extending neurites, and branching, as well as promoting cellular survival/proliferation. Interestingly, although NGF treatment increased the total number of branches, it actually decreased the proportion of branches per neurite length. The authors observed no differences in results obtained using the manual and automated systems, but the automated system was orders of magnitude faster. To demonstrate the flexibility of the system, the authors also show that they could measure changes in differentiation induced by a small-molecule Rho kinase inhibitor, as well as by retinoic acid cotreatment with brain-derived neurotrophic factor. In addition to this flexibility, this system does not require specialized equipment or fluorescent antibodies for analysis and therefore provides a less resource-intensive alternative to fluorescence-based systems.
Price
Raymond D
RD
Department of Neuroscience, Pharmacology Research Laboratories, Astellas Pharma Inc., Tsukuba, Japan.
Oe
Tomoya
T
Yamaji
Takayuki
T
Matsuoka
Nobuya
N
D016590:Aphidicolin / Q000494:pharmacology; D019208:Brain-Derived Neurotrophic Factor / Q000494:pharmacology*; D002452:Cell Count; D002454:Cell Differentiation / Q000187:drug effects; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D002999:Clone Cells; D004357:Drug Synergism; D006801:Humans; D020932:Nerve Growth Factor / Q000494:pharmacology*; D016501:Neurites / Q000737:chemistry* / Q000648:ultrastructure; D014212:Tretinoin / Q000494:pharmacology*; D020741:rho GTP-Binding Proteins / Q000037:antagonists & inhibitors*
D019208:Brain-Derived Neurotrophic Factor; D016590:Aphidicolin; D014212:Tretinoin; D020932:Nerve Growth Factor; D020741:rho GTP-Binding Proteins